Search
Filters
Clear All
  • 15
  • 52
  • 2
  • 647

Phase

  • 1
  • 11
  • 14
  • 47
  • 7
  • 66
  • 6
  • 541
  • 654
  • 299

Found 716 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Cardiogenic Shock Working Group Registry.

M
Maya Guglin
18-100 years
All genders
The objective of the registry is to collect de-identified clinical variables from the medical records and follow-up phone calls of shock patients from multiple institutions and centralize this data to a single registry for analysis of clinical outcomes.
Learn More

Safety, Tolerability, and Pharmacokinetics of GS-8588 in People With HIV-1 Who are Virologically Suppressed on Antiretroviral Therapy

S
Samir Gupta, MD
18-100 years
All genders
To evaluate the safety and tolerability of escalating, single and multiple intravenous (IV)doses GS-8588, administered in PWH who are virologically suppressed on ARTTo evaluate the PK of GS-8588
Learn More

The Rare Brain Tumour Consortium Registry and Biobank

S
Scott Coven
18 years and younger
All genders
What is the purpose of this study?The Biobank being created by this study is located at the Hospital for Sick Children in Toronto, Canada and is a research registry that collects biological samples and medical information from individuals in participating centers around the world. The purpose of this registry is …
Learn More

Biomarkers for susceptibility of Transplant Associated Respiratory failure (BioSTAR)

C
Courtney Rowan, MD
26 years and younger
All genders
What is the purpose of this study?People who undergo stem cell transplantation are at risk for lung complications.  The purpose of this research is to determine if markers in blood can help identify those patients who are at the greatest risk for lung complications, including the need for respiratory support.  THIS …
Learn More

Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study

S
Shadia Jalal, MD
18-100 years
All genders
Phase 3
What is this study about?This trial compares the effect of the combination of ramucirumab and pembrolizumab versus standard of care chemotherapy for the treatment of non-small cell lung cancer that is stage IV or that has come back after a period of improvement (recurrent). Ramucirumab is a monoclonal antibody that …
Learn More

Long term outcomes and quality of life in PHACE syndrome

A
Anita Haggstrom, MD
10-100 years
All genders
In this study, we will investigate outcomes, symptoms, and their impact on quality of life in adolescents and adults with PHACE syndrome in ages 10 years and up. This study will be the largest investigation into long term outcomes of PHACE and the first to capture the experiences of adolescents …
Learn More

Multicenter Phenotype-Genotype Analysis of Vascular Anomalies and Related Syndromes

A
Anita Haggstrom, MD
7-100 years
All genders
The purpose of this research is to develop a better understanding of the cause and natural history of vascular anomalies, discrepancies of growth, and related syndromes.
Learn More

Incorporating mind-body skills with diabetes education in adolescents with type 1 diabetes

T
Tamara Hannon, MD
15-17 years
All genders
We propose a study that incorporates mind-body skills with diabetes education specifically designed for adolescents with T1D.  To our knowledge, this is the first of such a study in adolescents with T1D.
Learn More

Registering Genomics and Imaging of Tumors

J
Jason Parker
18-89 years
All genders
What is the purpose of this study?This research is being done to see if genetic mutations inside brain tumors can be identified using pictures from MRI or PET scanners, instead of using needles or surgery. To conduct the study, we need to take pictures of the locations of tumor samples …
Learn More

PIONEER TEENS

T
Tamara Hannon, MD
10-18 years
All genders
To confirm superiority of oral semaglutide at the maximum tolerated dose (3 mg, 7 mg or 14 mg)versus placebo on glycaemic control in children and adolescents (age 10 to less than 18 years) with type 2 diabetes on a background treatment of metformin or basal insulin or both.
Learn More
271 - 280 of 716